Faron Obtains Debt Funding from IPF Partners
Faron Pharmaceuticals Ltd. (“Faron or Company”) Faron Obtains Up to EUR 30 Million Debt Funding from IPF Partners to Advance and Accelerate Pipeline · Financing of up to EUR 30 million through a loan from IPF Partners · Initial tranche consists of EUR 10 million · Proceeds from first tranche provide the Company with sufficient working capital through Q4 2022 · The utilization of two additional tranches of EUR 5 million and EUR 15 million, respectively, is subject to certain conditions precedent · IPF Partners will also be granted warrants entitling them to